Bluebird bio Inc (NASDAQ: BLUE) on Friday, plunged -5.17% from the previous trading day, before settling in for the closing price of $1.16. Within the past 52 weeks, BLUE’s price has moved between $0.88 and $5.53.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company achieved an average annual earnings per share of 10.88%. With a float of $189.83 million, this company’s outstanding shares have now reached $192.74 million.
Bluebird bio Inc (BLUE) Insider Updates
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Bluebird bio Inc is 1.51%, while institutional ownership is 61.93%. The most recent insider transaction that took place on Mar 04 ’24, was worth 9,311. In this transaction President and CEO of this company sold 6,095 shares at a rate of $1.53, taking the stock ownership to the 279,998 shares. Before that another transaction happened on Mar 04 ’24, when Company’s insider sold 4,573 for $1.53, making the entire transaction worth $6,986. This insider now owns 124,840 shares in total.
Bluebird bio Inc (BLUE) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of 171.54 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 10.88% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 45.80% during the next five years compared to 15.14% growth over the previous five years of trading.
Bluebird bio Inc (NASDAQ: BLUE) Trading Performance Indicators
Bluebird bio Inc (BLUE) is currently performing well based on its current performance indicators. A quick ratio of 1.42 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 9.76.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.74, a number that is poised to hit -0.44 in the next quarter and is forecasted to reach -0.88 in one year’s time.
Technical Analysis of Bluebird bio Inc (BLUE)
Let’s dig in a bit further. During the last 5-days, its volume was 4.32 million. That was inferior than the volume of 9.06 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 14.10%. Additionally, its Average True Range was 0.13.
During the past 100 days, Bluebird bio Inc’s (BLUE) raw stochastic average was set at 4.75%, which indicates a significant decrease from 8.57% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 98.07% in the past 14 days, which was lower than the 166.74% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.2582, while its 200-day Moving Average is $2.5666. However, in the short run, Bluebird bio Inc’s stock first resistance to watch stands at $1.1667. Second resistance stands at $1.2333. The third major resistance level sits at $1.2817. If the price goes on to break the first support level at $1.0517, it is likely to go to the next support level at $1.0033. Assuming the price breaks the second support level, the third support level stands at $0.9367.
Bluebird bio Inc (NASDAQ: BLUE) Key Stats
Market capitalization of the company is 212.01 million based on 109,336K outstanding shares. Right now, sales total 3,600 K and income totals -266,580 K. The company made 12,390 K in profit during its latest quarter, and -71,730 K in sales during its previous quarter.
